Patients as Partners in Clinical Research

Boston Boston, MA, United States

12th Annual: Demonstrating HOW Patient Involvement Gets Done to Enhance Access and Accelerate Medicine Development Patients as Partners® in Clinical Research is the first conference dedicated to raising the patient voice in R&D to drive better clinical outcomes for all. Guided by a steering commitee of Pharma R&D leaders, the FDA, patient advocates, and engagement professionals, the program...

The Rare Disease Summit

Philadelphia Philadelphia, PA, United States

          The Rare Disease Summit connects key stakeholders to drive therapeutic progress, propel commercial strategies and inspire impactful advocacy. You’ll generate solution-focused approaches surrounding patient access, reimbursement, commercialization, launch, partnering and more, as you unify in areas of unmet medical need. Learn more at www.informaconnect.com/rare and save 10% using code 25B4B10.*

PAP Conference 2025

Philadelphia Philadelphia, PA, United States

            Stakeholders unite at the ultimate forum – PAP – Patient Assistance & Access Programs convenes influential stakeholders and top leaders from across the assistance, access and affordability arena to talk strategies for program optimization and provide crucial updates on evolving health policy and shifting market dynamics to transform patient outcomes,...

Hub and Specialty Pharmacy Models East

Philadelphia Philadelphia, PA, United States

            Unlock your hub’s fullest potential at Hub and Specialty Pharmacy Models East. Key stakeholders unite to collaborate and discuss evolving regulations, shifting market dynamics and innovative solutions to accelerate access and drive an all-encompassing, state-of-the-art hub. Prepare for contemporary solutions to optimize your hub model and robust networking opportunities to...

Immuno-Oncology 360º

Boston Boston, MA, United States

IO360° Delivers 4 Key Benefits 1. Delivering a 360° IO Community​ to Network and Form Collaborations Build faster and more impactful collaborations with researchers, clinicians, biopharma leaders, investors and policymakers to advance cancer treatments 2. The Latest Data Driving Broader Impact Hear directly from KOLs on the latest data to help advance and improve outcomes for more...